Smart oxygen machine could prevent dangerous levels in hospital patients

NCT ID NCT06374225

Completed Disease control Sponsor: University of Colorado, Denver Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a device that automatically adjusts oxygen levels for hospitalized patients with serious injuries or illnesses. 300 adults received either the automated device or standard manual oxygen adjustments. The goal was to see if the device kept oxygen levels in a safer range (90-96%) during the first 72 hours of care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Automated oxygen titration device (O2matic PRO100)
What this could lead to: If successful, this device could help hospitals keep patients' oxygen levels in a safer range automatically, reducing complications from too much or too little oxygen.
What could go wrong: This is a completed trial with 300 participants, but results may not apply to all patients or settings. The device may not improve outcomes like survival or length of stay.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

burn Critical Illness Disease Attributes Hyperoxia Hypoxia injury Pathologic Processes

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CRITICAL ILLNESS DISEASE ATTRIBUTES PATHOLOGIC PROCESSES WOUNDS AND INJURY

Contacts and locations

Locations

Atrium Health Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, 27157, United States
Oregon Health and Sciences University

Portland, Oregon, 97239, United States
University of Colorado

Aurora, Colorado, 80045, United States
Vanderbilt University Medical Center

Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.